$272 Thousand is the total value of Krensavage Asset Management, LLC's 12 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | UNITED THERAPEUTICS CORP | $45,450 | +1.6% | 201,222 | -0.7% | 16.73% | +18.0% |
| EXEL | Sell | EXELIXIS INC | $41,496 | +1.8% | 1,899,151 | -11.0% | 15.28% | +18.3% |
| BIIB | Sell | BIOGEN INC | $41,245 | -18.1% | 160,480 | -9.2% | 15.19% | -4.8% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $38,890 | -8.6% | 47,256 | -20.2% | 14.32% | +6.3% |
| ALKS | Sell | ALKERMES PLC | $25,379 | -26.5% | 906,060 | -17.9% | 9.34% | -14.6% |
| CAH | Sell | CARDINAL HEALTH INC | $25,292 | -24.4% | 291,319 | -17.6% | 9.31% | -12.1% |
| TARO | Sell | TARO PHARMACEUTICAL INDUS | $24,162 | -0.9% | 640,735 | -0.4% | 8.90% | +15.1% |
| Buy | EMBECTA CORP | $17,531 | -24.2% | 1,164,876 | +8.8% | 6.46% | -11.9% | |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $8,211 | -44.2% | 735,103 | +6.9% | 3.02% | -35.2% |
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $1,777 | -19.4% | 112,666 | -0.7% | 0.65% | -6.4% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $1,557 | -34.9% | 360,429 | -0.7% | 0.57% | -24.4% |
| KOD | Sell | KODIAK SCIENCES INC | $616 | -74.1% | 342,312 | -0.7% | 0.23% | -69.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.